Mrs. Suzanne S Cleland Zamudio, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 100 E Jackson Ave Ste 102, Ellensburg, WA 98926 Phone: 509-933-8860 Fax: 509-933-8870 |
News Archive
Flamel Technologies today announced the initiation of a Phase 2a clinical trial of Flamel's Interferon alpha-2b XL (IFN-alpha-2b XL), which is based on Flamel's Medusa® platform for controlled release of biologics. IFN-alpha-2b XL is being developed as a controlled release of unmodified interferon alpha-2b for the treatment of chronic hepatitis C virus (HCV).
The two Republican rivals are both campaigning on their zeal to repeal the health law. Meanwhile, Rep. Chris Van Hollen, D-Md., says during the Sunday talk shows that he expects modifications to the health law to iron out its kinks will be necessary at some point down the road.
In today's headlines, reports about how Medicare, Medicaid and the health care industry might fare in the ongoing budget negotiations.
A new anti-blood clotting drug – Xarelto (rivaroxaban) has shown clinical success. It may help people with "acute coronary syndrome" lower their risk of death, subsequent heart attack or stroke, a new study finds. Acute coronary syndrome is term that includes people with angina or prior history of heart attack.
A man who was paralysed from the shoulders down has been able to feed himself and drink as a result of a novel neuro-prosthesis which reconnects his brain with his muscles.
› Verified 6 days ago